(Q37954422)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

title

Stem cell challenges in the treatment of neurodegenerative disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

Zhongling Feng

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

Feng Gao

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

publication date

26 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

CNS Neuroscience & Therapeutics

16 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

page(s)

142-148

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

Neurodegenerative diseases: an overview of environmental risk factors

16 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Stem cells: an overview of the current status of therapies for central and peripheral nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Stem cells in human neurodegenerative disorders--time for clinical translation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Progress toward the clinical application of patient-specific pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Stem cell transplantation for neurometabolic and neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Cell replacement therapy for Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Treatment of Parkinson's disease model mice with allogeneic embryonic stem cells: necessity of immunosuppressive treatment for sustained improvement.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Prospects of stem cell therapy for replacing dopamine neurons in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Pluripotency of mesenchymal stem cells derived from adult marrow

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Bone marrow stromal stem cells: nature, biology, and potential applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Neurons derived from reprogrammed fibroblasts functionally integrate into the fetal brain and improve symptoms of rats with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Induction of pluripotent stem cells from adult human fibroblasts by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Lentiviral delivery of LMX1a enhances dopaminergic phenotype in differentiated human bone marrow mesenchymal stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Cell-based therapies in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Parkinson's disease patient-derived induced pluripotent stem cells free of viral reprogramming factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Cell type analysis of functional fetal dopamine cell suspension transplants in the striatum and substantia nigra of patients with Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Transplantation of subventricular zone neural precursors induces an endogenous precursor cell response in a rat model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Increased sensitivity of myoblasts to oxidative stress in amyotrophic lateral sclerosis peripheral tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Hematopoietic stem cell transplantation in patients with sporadic amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

ALS model glia can mediate toxicity to motor neurons derived from human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Human embryonic stem cell-derived motor neurons are sensitive to the toxic effect of glial cells carrying an ALS-causing mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Induced pluripotent stem cells from a spinal muscular atrophy patient

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Mesenchymal stem cells as trojan horses for GDNF delivery in ALS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Direct muscle delivery of GDNF with human mesenchymal stem cells improves motor neuron survival and function in a rat model of familial ALS

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Stem-cell transplantation into the frontal motor cortex in amyotrophic lateral sclerosis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Treatment of amyotrophic lateral sclerosis patients by autologous bone marrow-derived hematopoietic stem cell transplantation: a 1-year follow-up.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Stem cells: comprehensive treatments for amyotrophic lateral sclerosis in conjunction with growth factor delivery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Neural stem cells and Alzheimer's disease: challenges and hope

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Adult neurogenesis, neural stem cells and Alzheimer's disease: developments, limitations, problems and promises

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Differential processing of amyloid-beta precursor protein directs human embryonic stem cell proliferation and differentiation into neuronal precursor cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Transplanted neural precursors enhance host brain-derived myelin regeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Intracerebroventricular transplantation of human mesenchymal stem cells induced to secrete neurotrophic factors attenuates clinical symptoms in a mouse model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Brain-derived neurotrophic factor gene delivery in an animal model of multiple sclerosis using bone marrow stem cells as a vehicle

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

A double-blind controlled trial of bilateral fetal nigral transplantation in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Transplantation of embryonic dopamine neurons for severe Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Adult stem cell therapies for neurological disorders: benefits beyond neuronal replacement?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Deconstructing stem cell tumorigenicity: a roadmap to safe regenerative medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Stem cells and cancer: a deadly mix.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Adult neurogenesis in the mammalian central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Gene therapy in Parkinson's disease: rationale and current status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Progress and prospects: Immunobiology of gene therapy for neurodegenerative disease: prospects and risks

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Gene therapy for neurological disorders: challenges and future prospects for the use of growth factors for the treatment of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Medicine. Gene therapy--new challenges ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Direct conversion of fibroblasts to functional neurons by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1755-5949.2011.00239.X

Neurogenesis in the adult brain

21 January 2018

1 reference

12 December 2020

A transcriptional logic for nuclear reprogramming

1 reference

12 December 2020

Stem cells and neurological diseases.

1 reference

12 December 2020

How to approach Alzheimer's disease therapy using stem cell technologies.

1 reference

12 December 2020

Future of cell and gene therapies for Parkinson's disease

1 reference

12 December 2020

Impact of magnetic labeling on human and mouse stem cells and their long-term magnetic resonance tracking in a rat model of Parkinson disease.

1 reference

12 December 2020

10.1111/J.1755-5949.2011.00239.X

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22070610%20AND%20SRC:MED&resulttype=core&format=json

16 January 2020

PubMed publication ID

22070610

1 reference